The Royal Victoria Hospital commonly known as "the Royal", the "RVH" or "the Royal Belfast", is a hospital in Belfast, Northern Ireland. It is managed by the Belfast Health and Social Care Trust.

During the past decade, Royal Victoria Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 21 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 15 clinical trials were completed. i.e. 65.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Victoria Hospital" #1 sponsor was "Abbott Medical Devices" with 9 trials, followed by "Belfast Health and Social Care Trust" with 5 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Edwards Lifesciences" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Victoria Hospital" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Queen's University, Belfast" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Royal Victoria Hospital" are "Coronary Artery Disease" (6 trials), "Crohn Disease" (4 trials), "Aortic Valve Stenosis" (3 trials), "Geographic Atrophy" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Royal Victoria Hospital" in a lesser frequency.

Most popular intervention types in "Royal Victoria Hospital" are "Drug" (33 trials), "Device" (30 trials), "Other" (12 trials), "Procedure" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Guselkumab" (3 trials), "Aspirin" (2 trials), "Etrolizumab" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Victoria Hospital" are 76 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Victoria Hospital". undefined are not yet recruiting, 16 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Royal Victoria Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Victoria Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 31 trials that are defined as “Not Applicable".